Stella PharmaSTELLA PHARMA CORPORATION4888東証グロース医薬品FY ending Mar 2026, non-consolidated, J-GAAP

Stella Pharma FY ending Mar 2021 results

Stella Pharma brought in ¥206M in revenue.

It lost about ¥331 for every ¥100 of sales at the operating level.

Where the money goes

For every ¥100 Stella Pharma sells, how much goes where, and how much is kept.

FY ending Mar 2021

Margin funnel (derived from reported values)Gross margin 88.3% → Operating margin -330.4% → Net margin -320.1%

Show source documents (4)

EDINET (FSA Japan)
有価証券報告書－第18期(2024/04/01－2025/03/31)
ID S100W6ZM2025-06-26Open
EDINET (FSA Japan)
有価証券報告書－第16期(2022/04/01－2023/03/31)
ID S100R76K2023-06-28Open
EDINET (FSA Japan)
有価証券報告書－第15期(令和3年4月1日－令和4年3月31日)
ID S100OKWQ2022-06-30Open
EDINET (FSA Japan)
有価証券報告書－第14期(令和2年4月1日－令和3年3月31日)
ID S100LUIT2021-06-30Open

Extracted from XBRL: 37 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.